Australia is welcome a groundbreaking treatment for weight issues: Retatrutide. The dual compound – working on both GLP-1 and GIP receptors – shows significant outcomes in clinical studies, pointing to meaningful decreases in body fat. While approval hasn't occurred with Australian regulators, a